Log In
Print this Print this

Catania coronary stent system

  Manage Alerts
Collapse Summary General Information
Company CeloNova BioSciences Inc.
DescriptionStent system with NanoThin Polyzene-F surface treatment
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentApproved
Standard IndicationCoronary artery disease (CAD)
Indication DetailsTreat de novo coronary artery lesions
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today